Bruno de Carvalho/SOPA Images/LightRocket via Getty Images AI cloud computing company CoreWave exploded onto the scene in March with the biggest tech IPO since 2021. The company’s stock soared by more than 40 percent in the following days, riding on the coattails of immense hype surrounding generative AI. The hype was driven by insatiable AI… Continue reading CoreWeave Has Lost a Staggering Amount of Stock Value Over the Past Six Months
Tag: Financial Results
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
PALO ALTO, Calif., Dec. 16, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced the pricing of an upsized underwritten public offering of 6,956,522 shares of its common stock at a price to the public of $23.00 per share. The… Continue reading Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
Uxin Announces Official Opening of Its Jinan Used Car Superstore
BEIJING, Dec. 16, 2025 /PRNewswire/ — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced the official opening of its used car superstore in the city of Jinan in Shandong Province. The Jinan location marks Uxin’s fifth large-scale superstore, following successful openings in Xi’an, Hefei, Wuhan, and Zhengzhou. Phase… Continue reading Uxin Announces Official Opening of Its Jinan Used Car Superstore
Millions Set to Lose Healthcare Coverage in 2026 as Policy Shifts Accelerate; Prescription Hope Keeps Brand-Name Medications Within Reach for Americans
STUART, Fla., Dec. 16, 2025 /PRNewswire/ — The United States is entering a period of significant disruption in healthcare coverage, according to health policy observers, with millions of Americans facing potential loss of coverage or sharply rising healthcare costs in the coming year. Estimates from the U.S. Department of Health and Human Services (HHS) and the… Continue reading Millions Set to Lose Healthcare Coverage in 2026 as Policy Shifts Accelerate; Prescription Hope Keeps Brand-Name Medications Within Reach for Americans
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 16, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the Malaysian National Pharmaceutical Regulatory Agency has approved a supplemental New Drug… Continue reading Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 16, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the Malaysian National Pharmaceutical Regulatory Agency has approved a supplemental New Drug… Continue reading Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
NEW YORK, Dec. 16, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. So what: If you purchased Perrigo… Continue reading PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth
NEW YORK, Dec. 16, 2025 /PRNewswire/ — This week, Sushi announced a major strategic development in the protocol’s long-term roadmap, backed by a significant investment from Synthesis, led by entrepreneur Alex McCurry. As part of this investment, Synthesis has acquired more than 10 million $SUSHI tokens, underscoring its conviction in Sushi’s future and its role in… Continue reading Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth
AGNICO EAGLE ANNOUNCES ADDITIONAL INVESTMENT IN OSISKO METALS INCORPORATED
Stock Symbol: AEM (NYSE and TSX) TORONTO, Dec. 16, 2025 /PRNewswire/ – Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) (“Agnico Eagle”) announced… Continue reading AGNICO EAGLE ANNOUNCES ADDITIONAL INVESTMENT IN OSISKO METALS INCORPORATED
Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering
NEW YORK, Dec. 16, 2025 /PRNewswire/ — Churchill Capital Corp XI (the “Company”) announced the pricing of its upsized initial public offering of 36,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “CCXIU” commencing today. Each unit consists of one Class A ordinary share… Continue reading Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering